Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia

European Respiratory Review

Volumn 16, Issue 103, 2007, Pages 45-49

  Drusano, G L ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

lactams; Appropriate antibiotic therapy; Broad spectrum antibiotics; Nosocomial pneumonia; Ventilator associated pneumonia

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN; DORIPENEM; MEROPENEM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBACTERIAL ACTIVITY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 34548157265     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010304     Document Type: Review

References (11)

1. Patel PJ, Leeper KV Jr, McGowan JE Jr. Epidemiology and microbiology of hospital-acquired pneumonia. Semin Respir Crit Care Med 2002; 23: 415-425.
2. Cavalcanti M, Valencia M, Torres A. Respiratory nosocomial infections in the medical intensive care unit. Microbes Infect 2005; 7: 292-301.
3. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33: 2184-2193.
4. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Drusano GL. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin Infect Dis 2003; 36: Suppl. 1, S42-S50.
6. Lomaestro BM, Drusano GL. Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation. Antimicrob Agents Chemother 2005; 49: 461-463.
7. Lodise TP Jr, Lomaestro B, Drusano GL. Piperacillintazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis 2007; 44: 357-363.
8. Andes DR, Kiem S, Craig W. In-vivo pharmacodynamic activity of a new carbapenem, doripenem (DOR), against multiple bacteria in a murine thigh infection model. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, American Society of Medicine, 2003.
9. Primaxin® I.M. (Imipenem and cilastatin for injectable suspension). Whitehouse Station, USA, Merck and Co., Inc., 2005.
10. Merrem™ Package Insert. Wilmington, USA, AstraZeneca, 2005.
11. Peninsula, Press Release at http://sec.edgar-online.com/2004/02/18/ 0000950134-04-002233/Section11.asp. Date last accessed: October 11, 2006.